AASS Gene: Aminoadipate-Semialdehyde Synthase

Genetic and Functional Insights into AASS, a Key Enzyme in Lysine Metabolism

Gene Information Card

Symbol AASS
Full Name Aminoadipate-Semialdehyde Synthase
Gene Type Protein coding
Chromosomal Location 7q31.32
NCBI Gene ID 10157 ncbi.nlm.nih.gov/gene/10157
Ensembl ID ENSG00000106333
UniProt ID Q9UDR5
OMIM ID 605113
HGNC ID 17366
Aliases LKR/SDH, LKRSDH, LORSDH, SAC3, SDH

Description

The AASS gene encodes aminoadipate-semialdehyde synthase, a bifunctional enzyme that catalyzes the first two steps of lysine degradation in the mitochondrial matrix. The enzyme possesses both lysine-ketoglutarate reductase (LKR) and saccharopine dehydrogenase (SDH) activities, converting lysine to saccharopine and then to α-aminoadipate-δ-semialdehyde. Mutations in AASS cause hyperlysinemia and saccharopinuria, autosomal recessive disorders of lysine metabolism.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hyperlysinemia Loss-of-function mutations in AASS impair lysine degradation, leading to elevated lysine levels in blood and urine. ClinVar, OMIM
Saccharopinuria Deficient saccharopine dehydrogenase activity results in accumulation of saccharopine, a variant of hyperlysinemia. ClinVar, OMIM

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 High
Kidney 6.8 Medium
Brain 3.2 Low
Heart 2.1 Low
Lung 1.5 Not detected
Cell Line Expression
Cell Line nTPM Notes
HepG2 15.3 Hepatocellular carcinoma cell line
HEK293 4.7 Embryonic kidney cells
SH-SY5Y 2.8 Neuroblastoma cell line
A549 1.2 Lung carcinoma cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1279C>T (p.Arg427*) Nonsense Rare Loss of function; associated with hyperlysinemia
c.1885G>A (p.Gly629Arg) Missense Rare Reduced enzymatic activity; reported in saccharopinuria
c.2662C>T (p.Arg888Trp) Missense Rare Impaired SDH activity; pathogenic in ClinVar
Mutation functional classification

Loss of Function (LOF)

Most pathogenic mutations in AASS result in loss of LKR and/or SDH enzymatic activity, leading to hyperlysinemia and saccharopinuria.

Gain of Function (GOF)

No gain-of-function mutations have been reported for AASS.

Dominant Negative (DN)

No dominant-negative effects have been described for AASS mutations; inheritance is autosomal recessive.

Gene Ontology (GO)

• GO:0003824 – catalytic activity • GO:0005739 – mitochondrion
• GO:0006559 – L-lysine catabolic process • GO:0016829 – lyase activity
• GO:0017160 – saccharopine dehydrogenase activity • GO:0030145 – manganese ion binding
• GO:0042802 – identical protein binding

Pathways

Lysine degradation (KEGG: hsa00310)
Metabolism of amino acids and derivatives (Reactome: R-HSA-71291)

Protein Summary

Aminoadipate-semialdehyde synthase is a mitochondrial bifunctional enzyme composed of two identical subunits. Each subunit contains an N-terminal lysine-ketoglutarate reductase domain and a C-terminal saccharopine dehydrogenase domain. The enzyme catalyzes the conversion of L-lysine to saccharopine (LKR activity) and subsequently to α-aminoadipate-δ-semialdehyde (SDH activity), using NADPH and NAD+ as cofactors. Deficiency leads to accumulation of lysine and saccharopine, causing metabolic disorders.

Related Products

Product name Cat.No. Species Gene ID
AASS Knockout HEK293 Cell Line EDJ-KQ6293 Human 10157 Details Get a Quote
AASS Knockout HCT 116 Cell Line EDJ-KQ31572 Human 10157 Details Get a Quote
AASS Knockout HeLa Cell Line EDJ-KQ31573 Human 10157 Details Get a Quote
AASS Knockout A-549 Cell Line EDJ-KQ63812 Human 10157 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: